GCVTX | RMFCX | GCVTX / RMFCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 17 years | 22 years | - |
Gain YTD | 21.232 | 16.440 | 129% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 398M | 104B | 0% |
Annual Yield % from dividends | 1.25 | 1.69 | 74% |
Returns for 1 year | 26.61 | 21.31 | 125% |
Returns for 3 years | 2.13 | 15.46 | 14% |
Returns for 5 years | 31.37 | 44.92 | 70% |
Returns for 10 years | 77.18 | 65.01 | 119% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FLUEX | 28.90 | -0.06 | -0.21% |
Fidelity Advisor Stk Selec Lg Cp Val C | |||
VSFSX | 27.93 | -0.28 | -0.99% |
Federated Hermes Clover Small Value R6 | |||
LGLIX | 48.29 | -0.84 | -1.71% |
Lord Abbett Growth Leaders I | |||
RYHCX | 29.15 | -0.68 | -2.28% |
Rydex Health Care C | |||
DRYQX | 20.58 | -0.48 | -2.28% |
BNY Mellon Research Growth Y |